Editorial: Inflammatory responses on the road from NASH to HCC: pathogenic mechanisms and possible therapeutic strategies.

Autor: Lukacs-Kornek V; Institute of Molecular Medicine and Experimental Immunology, University Hospital Bonn of the Rheinische Friedrich-Wilhelms-University, Bonn, Germany., Hendrikx T; Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria., Sutti S; Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Nov 01; Vol. 15, pp. 1512363. Date of Electronic Publication: 2024 Nov 01 (Print Publication: 2024).

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.

Autor: Foglia B; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Sutti S; Department Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University Amedeo Avogadro of Eastern Piedmont, Novara, Italy., Cannito S; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Rosso C; Department Medical Sciences, University of Torino, and Division of Gastroenterology, San Giovanni Hospital, Torino, Italy., Maggiora M; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Casalino A; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Bocca C; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Novo E; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Protopapa F; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy., Ramavath NN; Department of Pediatrics, School of Medicine, Washington University, St Louis, MO, United States., Provera A; Department Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University Amedeo Avogadro of Eastern Piedmont, Novara, Italy., Gambella A; Department Medical Sciences, University of Torino, and Division of Gastroenterology, San Giovanni Hospital, Torino, Italy., Bugianesi E; Department Medical Sciences, University of Torino, and Division of Gastroenterology, San Giovanni Hospital, Torino, Italy., Tacke F; Department of Hepatology and Gastroenterology, Charité-Universitatsmedizin Berlin, Berlin, Germany., Albano E; Department Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University Amedeo Avogadro of Eastern Piedmont, Novara, Italy., Parola M; Department Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Feb 26; Vol. 15, pp. 1342404. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).

Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation.

Autor: Puricelli C; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; Maggiore della Carità University Hospital, Corso Mazzini 18, 28100 Novara, Italy., Gigliotti CL; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; NOVAICOS s.r.l.s, Via Amico Canobio 4/6, 28100 Novara, Italy., Stoppa I; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy., Sacchetti S; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; Maggiore della Carità University Hospital, Corso Mazzini 18, 28100 Novara, Italy., Pantham D; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; NOVAICOS s.r.l.s, Via Amico Canobio 4/6, 28100 Novara, Italy., Scomparin A; Department of Drug Science and Technology, University of Torino, 10125 Turin, Italy.; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel., Rolla R; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; Maggiore della Carità University Hospital, Corso Mazzini 18, 28100 Novara, Italy., Pizzimenti S; Department of Clinical and Biological Science, University of Turin, Corso Raffaello 30, 10125 Torino, Italy., Dianzani U; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; Maggiore della Carità University Hospital, Corso Mazzini 18, 28100 Novara, Italy., Boggio E; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; NOVAICOS s.r.l.s, Via Amico Canobio 4/6, 28100 Novara, Italy., Sutti S; Department of Health Sciences, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.

Publikováno v: Pharmaceutics [Pharmaceutics] 2023 Jun 20; Vol. 15 (6). Date of Electronic Publication: 2023 Jun 20.

Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses.

Autor: Foglia B; Unit of Experimental Medicine and Clinical Pathology, Department of Clinical and Biological Sciences, University of Torino, 10125 Torino, Italy., Beltrà M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain., Sutti S; Department of Health Sciences, Interdisciplinary Research Center for Autoimmune Diseases, University of East Piedmont, 28100 Novara, Italy., Cannito S; Unit of Experimental Medicine and Clinical Pathology, Department of Clinical and Biological Sciences, University of Torino, 10125 Torino, Italy.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 18; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 18.

Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering.

Autor: Gigliotti CL; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.; NOVAICOS s.r.l.s, Via Amico Canobio 4/6, 28100 Novara, Italy., Dianzani C; Department of Scienza e Tecnologia del Farmaco, University of Turin, 10125 Turin, Italy., Stoppa I; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy., Monge C; Department of Scienza e Tecnologia del Farmaco, University of Turin, 10125 Turin, Italy., Sutti S; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy., Sblattero D; Department of Life Sciences, University of Trieste, 34127 Trieste, Italy., Puricelli C; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.; Clinical Biochemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, Italy., Rolla R; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.; Clinical Biochemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, Italy., Dianzani U; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.; Clinical Biochemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, Italy., Boggio E; Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.; NOVAICOS s.r.l.s, Via Amico Canobio 4/6, 28100 Novara, Italy.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 02; Vol. 24 (3). Date of Electronic Publication: 2023 Feb 02.